Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Yu T, Vollenweider D, Varadhan R, Li T, Boyd C, Puhan MA. Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines. BMC Med. 2013 Jan 9;11:7. doi: 10.1186/1741-7015-11-7. PubMed PMID: 23302096; PubMed Central PMCID: PMC3565912.
Ter Riet G, Chesley P, Gross AG, Siebeling L, Muggensturm P, Heller N, Umbehr M, Vollenweider D, Yu T, Akl EA, Brewster L, Dekkers OM, Mühlhauser I, Richter B, Singh S, Goodman S, Puhan MA. All that glitters isn't gold: a survey on acknowledgment of limitations in biomedical studies. PLoS One. 2013;8(11):e73623. doi: 10.1371/journal.pone.0073623. eCollection 2013. PubMed PMID: 24324540; PubMed Central PMCID: PMC3854521.
Yu T, Fain K, Boyd CM, Singh S, Weiss CO, Li T, Varadhan R, Puhan MA. Benefits and harms of roflumilast in moderate to severe COPD. Thorax. 2014 Jul;69(7):616-22. doi: 10.1136/thoraxjnl-2013-204155. Epub 2013 Dec 17. PubMed PMID: 24347460; PubMed Central PMCID: PMC4455881.
Li T, Saldanha IJ, Vedula SS, Yu T, Rosman L, Twose C, N Goodman S, Dickersin K. Learning by doing-teaching systematic review methods in 8 weeks. Res Synth Methods. 2014 Sep;5(3):254-63. doi: 10.1002/jrsm.1111. Epub 2014 Feb 14. PubMed PMID: 26052850.
Michelessi M, Lindsley K, Yu T, Li T. Combination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysis. Cochrane Database Syst Rev. 2014 Nov;2014(11). doi: 10.1002/14651858.CD011366. PubMed PMID: 25774087; PubMed Central PMCID: PMC4356167.
Juo YY, Johnston FM, Zhang DY, Juo HH, Wang H, Pappou EP, Yu T, Easwaran H, Baylin S, van Engeland M, Ahuja N. Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis. Ann Oncol. 2014 Dec;25(12):2314-27. doi: 10.1093/annonc/mdu149. Epub 2014 Apr 8. Review. PubMed PMID: 24718889; PubMed Central PMCID: PMC4239805.
Yu T, Li T, Lee KJ, Friedman DS, Dickersin K, Puhan MA. Setting priorities for comparative effectiveness research on management of primary angle closure: a survey of Asia-Pacific clinicians. J Glaucoma. 2015 Jun-Jul;24(5):348-55. doi: 10.1097/IJG.0b013e31829e5616. PubMed PMID: 23835674; PubMed Central PMCID: PMC3883875.
Puhan MA, Yu T, Boyd CM, Ter Riet G. Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPD. BMC Med. 2015 Jul 2;13:157. doi: 10.1186/s12916-015-0398-0. PubMed PMID: 26137986; PubMed Central PMCID: PMC4490602.
Stegeman I, Bossuyt PM, Yu T, Boyd C, Puhan MA. Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis. PLoS One. 2015;10(7):e0127194. doi: 10.1371/journal.pone.0127194. eCollection 2015. PubMed PMID: 26151751; PubMed Central PMCID: PMC4494891.
Li T, Yu T, Hawkins BS, Dickersin K. Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis. PLoS One. 2015;10(8):e0133023. doi: 10.1371/journal.pone.0133023. eCollection 2015. PubMed PMID: 26284684; PubMed Central PMCID: PMC4540315.
Yu T, Holbrook JT, Thorne JE, Flynn TN, Van Natta ML, Puhan MA. Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study. Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6864-72. doi: 10.1167/iovs.15-16705. PubMed PMID: 26501236; PubMed Central PMCID: PMC4627251.
Puhan MA, Yu T, Stegeman I, Varadhan R, Singh S, Boyd CM. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer. BMC Med. 2015 Oct 1;13:250. doi: 10.1186/s12916-015-0493-2. PubMed PMID: 26423305; PubMed Central PMCID: PMC4589917.
Yu T, Hsu YJ, Fain KM, Boyd CM, Holbrook JT, Puhan MA. Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey. BMJ Open. 2015 Nov 27;5(11):e007960. doi: 10.1136/bmjopen-2015-007960. PubMed PMID: 26614616; PubMed Central PMCID: PMC4663404.
Yu T, Holbrook JT, Thorne JE, Puhan MA. Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis. Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):363-71. doi: 10.1002/pds.3959. Epub 2016 Jan 22. PubMed PMID: 26798977; PubMed Central PMCID: PMC5535264.
Fain KM, Yu T, Li T, Boyd CM, Singh S, Puhan MA. Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations. J Clin Epidemiol. 2016 Jun;74:151-7. doi: 10.1016/j.jclinepi.2016.02.018. Epub 2016 Mar 3. PubMed PMID: 26939932.
Yu T, Frei A, Ter Riet G, Puhan MA. Determinants of Physical Activity in Patients with Chronic Obstructive Pulmonary Disease: A 5-Year Prospective Follow-Up Study. Respiration. 2016;92(2):72-9. doi: 10.1159/000447975. Epub 2016 Jul 13. PubMed PMID: 27404667.
Yu T, Ter Riet G, Puhan MA, Frei A. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Prim Care Respir Med. 2017 May 18;27(1):36. doi: 10.1038/s41533-017-0034-x. PubMed PMID: 28522822; PubMed Central PMCID: PMC5437069.
Bennett WL, Robbins CW, Bayliss EA, Wilson R, Tabano H, Mularski RA, Chan WV, Puhan M, Yu T, Leff B, Li T, Dickersin K, Glover C, Maslow K, Armacost K, Mintz S, Boyd CM. Engaging Stakeholders to Inform Clinical Practice Guidelines That Address Multiple Chronic Conditions. J Gen Intern Med. 2017 Aug;32(8):883-890. doi: 10.1007/s11606-017-4039-5. Epub 2017 Mar 27. PubMed PMID: 28349409; PubMed Central PMCID: PMC5515786.
Yu T, Enkh-Amgalan N, Zorigt G. Methods to perform systematic reviews of patient preferences: a literature survey. BMC Med Res Methodol. 2017 Dec 11;17(1):166. doi: 10.1186/s12874-017-0448-8. PubMed PMID: 29228914; PubMed Central PMCID: PMC5725984.
Yu T, Frei A, Ter Riet G, Puhan MA. Impact of Stressful Life Events on Patients with Chronic Obstructive Pulmonary Disease. Respiration. 2018;95(2):73-79. doi: 10.1159/000481714. Epub 2017 Nov 1. PubMed PMID: 29156451.
Koya C, Yu T, Strong C, Tsai MC. Association between Two Common Missense Substitutions, Thr6Lys and Val81Ile, in MC3R Gene and Childhood Obesity: A Meta-Analysis. Child Obes. 2018 May/Jun;14(4):218-226. doi: 10.1089/chi.2017.0265. Epub 2018 Apr 24. PubMed PMID: 29688747.
Yebyo HG, Aschmann HE, Yu T, Puhan MA. Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts. BMC Cardiovasc Disord. 2018 May 18;18(1):97. doi: 10.1186/s12872-018-0838-9. PubMed PMID: 29776337; PubMed Central PMCID: PMC5960214.
Shen TY, Chen HJ, Pan WH, Yu T. Secular trends and associated factors of age at natural menopause in Taiwanese women. Menopause. 2019 May;26(5):499-505. doi: 10.1097/GME.0000000000001307. PubMed PMID: 30672884.
Zorigt G, Enkh-Amgalan N, Yu T. Use of best-worst scaling to estimate the magnitude of stressful life events in older adults. Psychogeriatrics. 2019 May;19(3):212-218. doi: 10.1111/psyg.12384. Epub 2018 Oct 24. PubMed PMID: 30358015.
Beau-Lejdstrom R, Crook S, Spanu A, Yu T, Puhan MA. Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials. Pharmaceut Med. 2019 Aug;33(4):331-339. doi: 10.1007/s40290-019-00287-y. PubMed PMID: 31933187.
Aschmann HE, Boyd CM, Robbins CW, Mularski RA, Chan WV, Sheehan OC, Wilson RF, Bennett WL, Bayliss EA, Yu T, Leff B, Armacost K, Glover C, Maslow K, Mintz S, Puhan MA. Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment. BMJ Open. 2019 Aug 30;9(8):e028438. doi: 10.1136/bmjopen-2018-028438. PubMed PMID: 31471435; PubMed Central PMCID: PMC6720326.
Yu T, Enkh-Amgalan N, Zorigt G, Hsu YJ, Chen HJ, Yang HY. Gender differences and burden of chronic conditions: impact on quality of life among the elderly in Taiwan. Aging Clin Exp Res. 2019 Nov;31(11):1625-1633. doi: 10.1007/s40520-018-1099-2. Epub 2019 Jan 2. PubMed PMID: 30604210.
Tsai CW, Huang HC, Chiang HY, Chung CW, Chiu HT, Liang CC, Yu T, Kuo CC. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease. Nephrol Dial Transplant. 2019 Dec 1;34(12):2066-2078. doi: 10.1093/ndt/gfy200. PubMed PMID: 29982714.
Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Chan WV, Mularski RA, Wilson RF, Bennett WL, Sheehan OC, Yu T, Yebyo HG, Leff B, Tabano H, Armacost K, Glover C, Maslow K, Mintz S, Boyd CM. Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling. Health Qual Life Outcomes. 2019 Dec 19;17(1):186. doi: 10.1186/s12955-019-1250-6. PubMed PMID: 31856842; PubMed Central PMCID: PMC6924040.
What would you like to do?
  • Page of 1